European Healthcare Expenditure on Pharmacies Share by Country (Million Euros)

The European healthcare expenditure on pharmacies shows significant variation by country. As of 2023, Germany leads with €35.26M, followed by France at €18.18M, and Spain at €10.19M. Countries like Austria, Poland, and the Netherlands stand much lower, indicating disparities in pharmacy spending. Year-on-year growth rates highlight fluctuations: Austria (14.51%), Portugal (6.69%), and Bulgaria (5.22%) display marked increases, whereas Norway (0.14%) and Belgium (0.84%) show minimal growth. The Compound Annual Growth Rate (CAGR) over the last five years provides insight into sustained trends and average annual increments.

Future trends to watch include demographic shifts, increased pharmaceutical innovations, and policy changes across the EU. Emphasis on digital healthcare solutions and personalized medicine may bolster pharmacy expenditures. Monitoring economic stability and healthcare reforms will be essential in predicting future developments in this sector.

Top countries in Healthcare Expenditure on Pharmacies Share by Country (Million Euros)

# 10 Countries Percent Last Year YoY 5-years CAGR
1 1 Germany 35.26 2023 +4.79% +6.14% View data
2 2 France 18.18 2023 -0.087% +1.88% View data
3 3 Spain 10.19 2023 +3.26% +4.19% View data
4 4 Austria 4.09 2023 +16.87% +14.51% View data
5 5 Poland 3.48 2023 +1.63% +1.78% View data
6 6 Netherlands 2.91 2023 +0.65% +1.53% View data
7 7 Belgium 2.6 2023 +0.18% +0.84% View data
8 8 Switzerland 2.54 2023 +2.68% +4.11% View data
9 9 Sweden 2.4 2023 +1.12% +1.21% View data
10 10 Greece 2.18 2023 -3.04% +1.67% View data

Latest reports

 US Erectile Dysfunction Market Report- Q1 2025

US Erectile Dysfunction Market Report- Q1 2025

The US Erectile Dysfunction (ED) market in Q1 2025 is navigating a challenging economic landscape marked by inflationary pressures, geopolitical tensions, and a...

 South Korea Erectile Dysfunction Market Report- Q4 2024

South Korea Erectile Dysfunction Market Report- Q4 2024

The South Korean Erectile Dysfunction (ED) market in the fourth quarter of 2024 is characterized by evolving consumer preferences, technological innovations, and economic...

 Spain Erectile Dysfunction Market Report- Q4 2024

Spain Erectile Dysfunction Market Report- Q4 2024

The fourth quarter of 2024 presents a dynamic period for the Erectile Dysfunction (ED) market in Spain, marked by significant developments and emerging...

Top Countries about Dysfunction Drug